Pulmonology
News from the FDA/CDC
FDA approves solriamfetol for daytime sleepiness treatment
Solriamfetol is the first dopamine and norepinephrine reuptake inhibitor approved to treat narcolepsy and obstructive sleep apnea.
News
Home oxygen therapy for children: New guidelines combine limited evidence, expert experience
The guidelines supplement a limited evidence base with expert opinion, experiences, and a pediatric-specific definition of hypoxemia
News
Survey: Americans support regulation of vaping products
Despite FDA efforts under Commissioner Scott Gottlieb to raise awareness of teen vaping, only 21% of those surveyed correctly responded that e-...
News from the FDA/CDC
Flu activity levels down, but outpatient visits highest since 1998-99
Outpatient visits for this point in the season are at their highest level since 1998-99.
Conference Coverage
Eisenmenger syndrome is a minefield for unwary physicians
SNOWMASS, COLO. –
News
Daily aspirin associated with lower risk of COPD flareup
Daily aspirin appears to reduce the incidence of moderate acute exacerbations – but not severe exacerbations – in patients with chronic...
News
Dupilumab to undergo FDA Priority Review for CRSwNP treatment
News from the FDA/CDC
Flu activity down for a second straight week
A similar 2-week decline occurred at the beginning of January.
News
Heart-harming toxins may hurt hookah smokers
An AHA scientific statement outlines the trends in use and the harmful effects of water pipe smoking among youth and adults.
Conference Coverage
Poor COPD management might increase MI risk in HIV
SEATTLE – Underuse of long-acting inhalers is an issue.